Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia
PHASE1CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
January 31, 2000
Primary Completion Date
March 31, 2006
Study Completion Date
March 31, 2006
Conditions
Acute Myelogenous LeukemiaMyelodysplasia
Interventions
BIOLOGICAL
autologous tumor cells
Trial Locations (1)
02115
Dana-Farber Cancer Institute, Boston
All Listed Sponsors
collaborator
Brigham and Women's Hospital
OTHER
lead
Dana-Farber Cancer Institute
OTHER
NCT00136422 - Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia | Biotech Hunter | Biotech Hunter